Session 9 – Winning the Global Competition with Taiwanese DNA
Date：28 July (Thursday)
Time: 14:00 – 15:30 (GMT+8)
Principal, Bio Fund
Taiwania Capital Management Corporation
Before joining Taiwania in 2021, Victoria was a seasoned international business executive with over 20 years of hands-on experience in the fields of oral and craniomaxillofacial implants, converging medical imaging technology, digital health, healthcare systems, and patient management in the US, Western Europe, and the ASEAN regions.
Her role in Taiwania Capital includes identifying investment opportunities, promoting bio-converging technologies, and evaluating health economics challenges in the healthcare ecosystem. Victoria currently serves on the boards of AIxMed (US/TW), Suono Bio (US), and Nanolive (Switzerland) engaging companies to develop and differentiate their value positioning to deliver a combination of quantitative and qualitative solutions to targeted patients and end-users.
Victoria holds an M.S. degree in health policy and management from National Taiwan University and is pursuing further graduate study in entrepreneurship and innovation management at the University of Illinois Urbana Champaign.